John Ramunas holds a PhD and conducted telomere research at Stanford in Helen Blau's lab; he is founder of Rejuvenation Technologies, which is developing mRNA-based telomere extension and has received FDA INTERACT clearance, Khosla Ventures seed funding, and admission to Y Combinator.
Intro paths
YC
John went through Y Combinator (Summer 2018) — any YC alum in your network can reach them through the YC community.
→
In turn, John can intro founders to Rejuvenation Technologies Inc.'s investors below.
Rejuvenation Technologies Inc.'s investors · 1
Co-founders
Glenn Markov· Founder<UNKNOWN>· MBBS MRCP FRACP MD FQA, Clinical Professor at U. of Queensland